Federal Register / Vol. 66, No. 121 / Friday, June 22, 2001 / Notices 33543

Emergency Management Agency, 500 C

Street, SW., Washington, DC 20472.

Russell Salter,

Chair, Federal Radiological Preparedness

Coordinating Committee.

[FR Doc. 01–15712 Filed 6–21–01; 8:45 am]

BILLING CODE 6718–06–U

FEDERAL RESERVE SYSTEM

Change in Bank Control Notices;

Acquisition of Shares of Bank or Bank

Holding Companies

The notificants listed below have

applied under the Change in Bank

Control Act (12 U.S.C. 1817(j)) and

§ 225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire a bank or bank

holding company. The factors that are

considered in acting on the notices are

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. The notices

also will be available for inspection at

the office of the Board of Governors.

Interested persons may express their

views in writing to the Reserve Bank

indicated for that notice or to the offices

of the Board of Governors. Comments

must be received not later than July 9,

2001

A. Federal Reserve Bank of San

Francisco (Maria Villanueva, Consumer

Regulation Group) 101 Market Street,

San Francisco, California 94105–1579:

1. Terrance Ray Sullivan, Elko,

Nevada; Carol Ann Sullivan, Elko,

Nevada; Patrick Sean Sullivan, Elko,

Nevada; Terrance LeRoy Sullivan, Twin

Falls, Idaho; Deborah Ann Hall, Twin

Falls, Idaho; Darren Eugene Hall, Twin

Falls, Idaho; Terrance Ryan Sullivan,

Las Vegas, Nevada; Gary Phillip

Sullivan, Staten Island, New York;

Ralph William Farley, Laguna Woods,

California; and Iris Gertrude Farley,

Laguna Woods, California; all to acquire

additional voting shares of Great Basin

Financial Corporation, Elko, Nevada,

and thereby indirectly acquire

additional voting of Great Basin Bank of

Nevada, Elko, Nevada.

Board of Governors of the Federal Reserve

System, June 19, 2001.

Robert deV. Frierson

Associate Secretary of the Board.

[FR Doc. 01–15732 Filed 6–21–01; 8:45 am]

BILLING CODE 6210–01–S

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank Holding Company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR Part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The applications listed below, as well

as other related filings required by the

Board, are available for immediate

inspection at the Federal Reserve Bank

indicated. The application also will be

available for inspection at the offices of

the Board of Governors. Interested

persons may express their views in

writing on the standards enumerated in

the BHC Act (12 U.S.C. 1842(c)). If the

proposal also involves the acquisition of

a nonbanking company, the review also

includes whether the acquisition of the

nonbanking company complies with the

standards in section 4 of the BHC Act

(12 U.S.C. 1843). Unless otherwise

noted, nonbanking activities will be

conducted throughout the United States.

Additional information on all bank

holding companies may be obtained

from the National Information Center

website at www.ffiec.gov/nic/.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than July 19, 2001.

A. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri

63166–2034:

1. BancStar, Inc., St. Louis, Missouri;

to acquire 100 percent of the voting

shares of Pacific BancStar, Inc., St.

Louis, Missouri, and thereby indirectly

acquire Bank Star, Pacific, Missouri.

B. Federal Reserve Bank of

Minneapolis (JoAnne F. Lewellen,

Assistant Vice President) 90 Hennepin

Avenue, Minneapolis, Minnesota

55480–0291:

1. First Western Bancorp, Inc., Huron,

South Dakota; to become a bank holding

company by acquiring 74.8 percent of

the voting shares of American Bank

Shares, Inc., Rapid City, South Dakota,

and thereby indirectly acquire American

State Bank of Rapid City, Rapid City,

South Dakota.

Board of Governors of the Federal Reserve

System, June 19, 2001.

Robert deV. Frierson

Associate Secretary of the Board.

[FR Doc. 01–15731 Filed 6–21–01; 8:45 am]

BILLING CODE 6210–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Healthcare Research and

Quality

National Advisory Council for

Healthcare Research and Quality:

Request for Nominations for Public

Members

AGENCY: Agency for Healthcare Research

and Quality, HHS.

ACTION: Request for nominations for

public members.

SUMMARY: 42 U.S.C. 299c, section 921 of

the Public Health Service (PHS Act),

established a National Advisory Council

for Healthcare Research and Quality (the

Council). The Council is to advise the

Secretary of HHS and the Director of the

Agency for Healthcare Research and

Quality (AHRQ), on matters related to

actions of the Agency to enhance the

quality, improve the outcomes, and

reduce the costs of health care services,

as well as improve access to such

services, through scientific research and

the promotion of improvements in

clinical practice and in the organization,

financing, and delivery of health care

services.

Seven current members’ terms will

expire in August 2001. To fill these

positions in accordance with the

legislative mandate establishing the

Council,, we are seeking individuals

who are distinguished in the conduct of

research, demonstration projects, and

evaluations with respect to health care;

individuals distinguished in the fields

of health care quality research or health

care improvement; individuals

distinguished in the practice of

medicine; individuals distinguished in

the practice of medicine; individuals

distinguished in the other health

professions; individuals either

representing the private health care

sector (including health plans,

providers, and purchasers) or

individuals distinguished as

administrators of health care delivery

systems; individuals distinguished in

the fields of health care economics,

management science, information

systems, law, ethics, business, or public

policy; and individuals representing the

interests of patients and consumers of

health care. Individuals are particularly

33544 Federal Register / Vol. 66, No. 121 / Friday, June 22, 2001 / Notices

sought with experience and success in

activities specified in the summary

paragraph above, through which the

Agency carries out its work.

DATES: Nominations should be received

on or before July 13, 2001.

ADDRESSES: Nominations should be sent

to Ms. Anne Lebbon, AHRQ, 2101 East

Jefferson Street, Suite 600, Rockville,

Maryland 20852. Nominations also may

be faxed to (301) 443–0251.

FOR FURTHER INFORMATION CONTACT: Ms.

Anne Lebbon, AHRQ, at (301) 594–

7216.

SUPPLEMENTARY INFORMATION: 42 U.S.C.

299c, section 921 of the PHS Act,

provides that the National Advisory

Council for Health are Research and

Quality shall consist of 21 appropriately

qualified representatives of the public

appointed by the Secretary of Health

and Human Services and eight ex officio

representatives from Federal agencies

conducting or supporting health care

research. The Council meets in the

Washington, DC, metropolitan area,

generally in Rockville, Maryland,

approximately three times a year to

provide broad guidance to the Secretary

and AHRQ’s Director on the direction

and programs for AHRQ.

Seven individuals will presently be

selected by the Secretary to serve on the

Council beginning with the meeting in

the fall of 2001. Members generally

serve 3-year terms. Appointments are

staggered to permit an orderly rotation

of membership.

Interested persons may nominate one

or more qualified persons for

membership on the Council.

Nominations shall include a copy of the

nominee’s resume or curriculum vitae,

and state that the nominee is willing to

serve as a member of the Council.

Potential candidates will be asked to

provide detailed information concerning

their financial interests, consultant

positions, and research grants and

contracts, to permit evaluation of

possible sources of conflict of interest.

The Department is seeking a broad

geographic representation and has

special interest in assuring that women,

minority groups, and the physically

handicapped and are adequately

represented on advisory bodies and,

therefore, extends particular

encouragement to nominations for

appropriately qualified female,

minority, and/or physically

handicapped candidates.

Dated: June 12, 2001.

John M. Eisenberg,

Director,

[FR Doc. 01–15665 Filed 6–21–01; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Administration on Aging

Agency Information Collection

Activities: Proposed Submission to the

Office of Management and Budget

(OMB) for Clearance; Comment

Request; Reinstatement of Previously

Approved Information Collection

AGENCY: Administration on Aging, HHS.

The Administration on Aging (AoA),

Department of Health and Human

Services, provides an opportunity for

comment on the following proposal for

the collection of information in

compliance with the Paperwork

Reduction Act (PRA; Pub. L. 96–511):

Title of Information Collection:

Reporting Requirements for the

Alzheimer’s Disease Demonstration

Grants to States Program and GPRA

data.

Type of Request: Reinstatement of a

previously approved collection for

which approval has expired.

Use: Data on persons served, services

provided, and program staff will be

collected semi-annually from

participants in the Alzheimer’s Disease

Demonstration Grants to States Program.

Data will be used for program

modification and evaluation, annual

Department reports, and a final report to

Congress as set forth by congressional

statute.

Frequency: Semi-annually.

Respondents: Agencies of State

Governments that have been designated

by the governor as the sole applicant for

the State and who have applied for a

grant under this program.

Estimated Number of Responses: 50/

year.

Total Estimated Burden Hours: 1,000/

year.

Additional Information or Comments:

The Administration on Aging plans to

submit to the Office of Management and

Budget for reinstatement of a previously

approved collection for which approval

has expired, for the Alzheimer’s Disease

Demonstration Grants to States Program,

pursuant to requirements set forth by

congressional statute. Written comments

and recommendations for the proposed

information collection should be sent

within 60 days of the publication of this

notice directly to the following address:

Office of Program Development,

Administration on Aging, Attention:

Melanie Starns, 330 Independence

Avenue, SW., Rm 4270, Washington, DC

20201.

Dated: June 18, 2001.

Norman L. Thompson,

Acting Principal Deputy Assistant Secretary

for Aging.

[FR Doc. 01–15728 Filed 6–21–01; 8:45 am]

BILLING CODE 4154–01–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Request for Interest in Participating in

the Selection of the Nonvoting

Members of Industry Interests on

Public Advisory Committees;

Nonprescription Drugs Advisory

Committee

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is filling the

position of nonvoting industry

representative on the Nonprescription

Drugs Advisory Committee. FDA

requests that any industry organization,

that is interested in participating in the

selection of an appropriate nonvoting

member of the Nonprescription Drugs

Advisory Committee to represent

industry, send a letter stating that

interest to the FDA employee designated

below within 30 days of the date of this

notice. In addition, if individuals or

organizations would like to nominate

individuals to serve as the nonvoting

industry representative, they may do so.

DATES: Letters of interest and

nominations should be received on or

before July 23, 2001.

ADDRESSES: All nominations for

membership should be submitted to

Sandra Titus (address below).

FOR FURTHER INFORMATION CONTACT:

Sandra Titus, Advisors and Consultants

Staff (HFD–21), Center for Drug

Evaluation and Research, Food and

Drug Administration, 5600 Fishers

Lane, Rockville, MD 20857, 301–827–

7001, e-mail: tituss@cder.fda.gov.

SUPPLEMENTARY INFORMATION:

I. Function

The function of the committee is to

review and evaluate available data

concerning the safety and effectiveness

of over-the-counter (nonprescription)

human drug products for use in

thetreatment of a broad spectrum of

human symptoms and diseases.

II. Selection Procedure

Any industry organization interested

in participating in the selection of an

appropriate nonvoting member of the